Conclusions-Clinical, procedural and angiographic variables increase the risk for early closure and restenosis after endoluminal stenting. The prediction models described above need to be validated prospectively. (Br HeartJ7 1995;74:592-597) 
Endoluminal implantation of metallic stents was introduced in 1986 as an alternative to conventional percutaneous transluminal coronary angioplasty (PTCA) for the treatment of abrupt closure and restenosis after PTCA.' Despite 8 years of clinical investigation and the promising results of the Benestent and STRESS trials, which favoured stenting over conventional balloon angioplasty for the treatment of de novo, focal stenoses in large native coronary arteries, reservations about stenting remain.23 These stem from the risk of early stent thrombosis: though its incidence has dropped dramatically from an initial rate of 20% to a recent rate of 3 5%, thrombosis remains the chief drawback of stenting.34 In addition, even if endoluminal stenting does reduce the process of restenosis it does not prevent it.
There are few studies of the risks of closure or restenosis after intracoronary stenting: only one study and a few abstracts on closure and four on restenosis, with different results and various statistical methods. The purpose of the present study was to develop a statistical model to predict and quantify the risk factors for both early closure and restenosis after endoluminal stenting at the time of intervention. This requires a large study population with appropriate clinical and angiographic follow up, comparable management before and after the procedure, consistent inclusion criteria during the study years and a high angiographic follow up rate-conditions best complied with in a single centre. We therefore analysed various clinical, procedural, and angiographic variables observed in consecutively stented patients during a 7 year study period and investigated their possible contribution to early closure and restenosis. Quantitative angiographic analysis was performed by an independent operator, using the "worst" view. Most (74%) angiographic films were analysed by means of the ANCOR system, while the remaining films were examined with the CASS system.7 This ANCOR system, derived from the CAAS algorithm, has been introduced and validated previously.8 Care was taken to produce films of good quality with full contrast filling of the stented segment and to routinely administer a vasolytic agent before the procedure. The study population was categorised with respect to the occurrence of early closure and/or restenosis and secondarily according to the clinical, procedural, and angiographic variables. Before analysis, continuous variables were split at the median and discrete variables were dichotomised when there were more than 2 subgroups. Effects were regarded as significant when the null hypothesis could be rejected at a 5% probability. Continuous variables are presented as means with their 95% confidence intervals and medians.
Initially, early closure and restenosis were studied separately and we screened for risk factors first by forward, stepwise multivariate regression analysis. All procedures, were considered when early closure was analysed. However, restenosis could not be or was not studied in patients who experienced early closure (permanent or temporary (because of successful recanalisation)) or who refused repeat angiography.
A second step consisted of a multivariate polychotomous logistic regression analysis that considered both closure and restenosis. This model permits the prediction at the time of intervention of both critical events. The rationale for this analysis was the assumption that patients who experience early closure may behave differently from "no closure" patients in terms of the late phenomenon of restenosis. Therefore each patient was regarded as being subject to closure and restenosis.
The statistical package (SAS) was used on a VAX-computer.
Results

PATIENT POPULATION
Between April 1986 and April 1993, 243 stenting procedures (in a total of 215 patients) were performed at our institution. Tables 1-3 show There was no significant difference in the incidence of closure (P = 0 27) and restenosis (P = 0 56) over the years.
We analysed risk factors for early closure for all procedures (n = 243), whereas only the 202 cases without closure at repeat angiography were analysed for restenosis risk factors: 40 had restenosis (19-8%). The six patients who refused repeat angiography had no clinical restenosis. Eight patients with early closure were successfully recanalised and two of these had restenosis. This closure subgroup was too small to be compared with the no closure group.
FORWARD, STEPWISE MULTIVARIATE REGRESSION
Closure
The following risk factors were retained in a forward, stepwise regression model: (a) the presence of collaterals (60% with v 11-4% without, P = 0 0001), (b) stenting of the LAD (30% with v 3-4% without for SVG and 5-6% for RCA, P = 0'0002) or the LCx (28%, P = 0 0001), (c) bailout stenting (24-4% with v 16-4% without, for restenosis treatment and 0% for de novo stenting of stenoses, P = 0 03), (d) age > 60 years (19- Table 4 shows different variables retained as risk factors for closure and restenosis. Table 5 shows the prediction of both critical events in men according to the presence of these risk factors.
Discussion
The primary success rate of percutaneous transluminal coronary angioplasty has improved dramatically since its introduction in 19779 mainly because of the refinement lesion selection and the improvement in operator's skill, which has resulted in fewer technical failures. However, the incidence of the technique's two major shortcomings, acute abrupt closure and late restenosis, has remained unchanged.'0 Endoluminal implantation of metallic stents has been performed in human coronary arteries since 1986 in an attempt to overcome both complications. From 1986 on, different stent types have been under clinical investigation. This first critical evaluation of these new devices in January 1991 was disappointing for the Wallstent, with an unacceptable high early stent thrombosis rate (up to 20%), and promising for the Palmaz-Schatz stent with less closure (3.7%). 4 This study examines risks factors for early closure and restenosis based on clinical, procedural, and angiographic variables observed in 243 successful stenting procedures. A thor- ough search of published reports found one paper and a few abstracts on risk factors for early closure; none mentioned the statistical methods. The risk factors identified were thrombocytosis, stents smaller than 3 mm, multiple Palmaz-Schatz stent implantation, and inability to stabilise the dissection by stenting in bailout cases."'-"3 Only one paper, by Nath et al (n = 145), identified lesion eccentricity and bailout stenting as risk factors for closure with the Gianturco-Roubin stent in a multivariate model.14 Risk factors for restenosis have been studied by Strauss et al (Wallstent, n = 214, 1991), Carrozza et al (Palmaz-Schatz, n = 250, 1992), Ellis et al (Palmaz-Schatz, n = 206, 1992), and de Jaegere et al (Wiktor stent, n = 91).14 18 Strauss used the binary restenosis (a ) 50% reduction compared with the reference diameter) criterion (criterion 1) and a criterion suggested by their group (a loss of > 0-72 mm in minimal luminal diameter at repeat angiography, criterion 2) and an odds ratio analysis. Risk factors according to criterion 1 and 2 were: multiple stenting and stent-vessel mismatch of 0 7 mm or more. They identified two other risk factors: vein graft stenting and postprocedural residual stenosis of > 20%. Their 95% confidence interval for the odds ratio, however, ranged from 0-91 to 2-67, which makes their conclusions debatable. Carrozza et al retained three variables from univariate analysis (diabetes mellitus, LAD stenting, and a postprocedural MLD of < 3-3 mm). They retained LAD stenting in a multivariate stepwise model. Ellis et al were the only investigators who removed early closures for their restenosis study. The risk factors tested in their multivariate logistic regression model were a history of restenosis, a postprocedural residual stenosis of > 0%, and multiple stent implantation. Only multiple stent implantation was an independent risk factor in this study. Otherwise, a residual stenosis of less than 0% has not been found in our experience and is seldom reported in published studies. Finally, de Jaegere et al in 91 Wiktor stent lesions found a relative gain (the acute gain normalised to the vessel size) of > 0-48 to be the only risk factor for restenosis according to the 0*72 mm late loss criterion.
In the present study, we decided to apply the binary restenosis criterion based on the generalised model for restenosis, proposed by Kuntz et al.19 One of the major criticisms of these investigators of the criterion of 0-72 mm late loss emerges from the present review of published reports. It has recently become apparent that a larger acute gain may be associated with more late loss of diameter.'8 Patients with an excellent angiographic result were more likely to fit into the 0-72 mm late loss criterion of restenosis in the study by Strauss et al and in the more recent work of de Jaegere et al. 15 18 The purpose of the present study was to investigate the ability to predict both early closure and restenosis at the time of implantation. An exploratory multivariate logistic regression was first performed for each critical event in order to detect possible risk factors.
This exploratory analysis for early closure suggested that the Wallstent was more thrombogenic than the Palmaz-Schatz stent. Subanalysis of our data shows that this is caused by a higher thrombosis rate in cases treated by placing short (.< 15 mm) Wallstents (8 in 22 for short v 14 in 111 for long Wallstents). A possible explanation for this observation may be incomplete sealing of the dissection by the shorter Wallstent which may increase the risk of closure. Despite an apparent similar thrombosis rate for the Wallstent (16 5%) and the Palmaz-Schatz stent (17 1%), the initial multivariate model predicts more closure with the Wallstent. This may be explained by the observed increased closure risk for stents < 15 mm (which includes the Palmaz-Schatz stents, that can not be counted twice in the multivariate model). In the global polychotomous model the initial disadvantage for the Wallstent was lost because this stent tended to induce fewer restenosis.
Five variables were retained in the final polychotomous model as risk factors for early closure and restenosis: one clinical characteristic (male gender), three procedural variables (LAD or LCx stenting, bailout stenting, multiple stent implantation), and one angiographic variable (the presence of collaterals).
Women had a more favourable outcome with less restenosis (about three times less than men) and the only independent variable that can be kept in the polychotomous model is the presence of collaterals to the target lesion, which increases the risk of early closure.
This study shows that the LAD and LCx behave comparably and are identified as a risk factor, mainly for closure. The relative risk for closure after stenting of the LAD or LCx is eight times that for the RCA and SVG.
Multiple stent implantation chiefly increases the risk of restenosis. This finding accords with the results of Strauss et al and Ellis et al. Three independent investigators found that multiple stent implantation doubled the risk of restenosis. Also, bailout stenting was found to be a risk factor for closure; however, it reduced the risk of restenosis. The presence of collaterals, which has not been suggested as a risk factor before, emerged as a powerful predictor for both restenosis and closure. In general, it seems that early closure is easier to predict (higher fi coefficient) than restenosis. 
